posted on 2017-12-21, 15:44authored byJohn Williams, Karen Finn, Vincent Melvin, DAVID MEAGHERDAVID MEAGHER, Geraldine McCarthy, Dimitrios Adamis
Limited studies of the association between BDNF levels and delirium have given inconclusive results. This prospective, longitudinal
study examined the relationship between BDNF levels and the occurrence of and recovery from delirium. Participants were assessed
twice weekly using MoCA, DRS-R98, and APACHE II scales. BDNF levels were estimated using an ELISA method. Delirium was
defined with DRS-R98 (score > 16) and recovery from delirium as ≥2 consecutive assessments without delirium prior to discharge.
We identified no difference in BDNF levels between those with and without delirium. Excluding those who never developed
delirium (𝑛 = 140), we examined the association of BDNF levels and other variables with delirium recovery. Of 58 who experienced
delirium, 39 remained delirious while 19 recovered. Using Generalized Estimating Equations models we found that BDNF levels
(Wald 𝜒2 = 7.155; df: 1, 𝑝 = 0.007) and MoCA (Wald 𝜒2 = 4.933; df: 1, 𝑝 = 0.026) were associated with recovery. No significant
association was found for APACHE II, dementia, age, or gender. BDNF levels do not appear to be directly linked to the occurrence
of delirium but recovery was less likely in those with continuously lower levels. No previous study has investigated the role of BDNF
in delirium recovery and these findings warrant replication in other populations.